Upgrade to SI Premium - Free Trial

Foundation Medicine (FMI) Tops Q3 EPS by 20c, Beats on Revenues; Offers FY17 Revenue Outlook

November 1, 2017 4:03 PM

Foundation Medicine (NASDAQ: FMI) reported Q3 EPS of ($0.90), $0.20 better than the analyst estimate of ($1.10). Revenue for the quarter came in at $42.7 million versus the consensus estimate of $37.99 million.

2017 Outlook

Foundation Medicine’s business and financial outlook for 2017 is the following:

The company expects 2017 revenue will be in the range of $135 million to $145 million.

Highlights

GUIDANCE:

Foundation Medicine sees FY2017 revenue of $135-145 million, versus the consensus of $141.33 million.

For earnings history and earnings-related data on Foundation Medicine (FMI) click here.

Categories

Earnings Guidance Hot Guidance